- 2024-08-20 02:14抑制剂Tazarotenic acid|Tazarotenic acid|118292-41-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TAS-119|TAS-119|1453099-83-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TAS-119|TAS-119|1453099-83-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂Tasosartan|Tasosartan|145733-36-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:14抑制剂Tasosartan|Tasosartan|145733-36-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂Tanzisertib|Tanzisertib|899805-25-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂Tapotoclax|Tapotoclax|1883727-34-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:14抑制剂Tapotoclax|Tapotoclax|1883727-34-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂TAS-119|TAS-119|1453099-83-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:14抑制剂Takinib|Takinib|1111556-37-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂Tanzisertib|Tanzisertib|899805-25-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:14抑制剂Tanzisertib|Tanzisertib|899805-25-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TAK-981|Subasumstat|1858276-04-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂Takinib|Takinib|1111556-37-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:14抑制剂Takinib|Takinib|1111556-37-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TAK-700|TAK-700|426219-18-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TAK-700|TAK-700|426219-18-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂TAK-981|Subasumstat|1858276-04-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:14抑制剂TAK-981|Subasumstat|1858276-04-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TAK-580|Tovorafenib|1096708-71-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
